We and others have shown that treatment of drug naïve cells with BET inhibitors results in the potent and rapid repression of a set of broadly expressed genes such as Myc, Bcl2 and Cdk6 that are essential for the survival of cancer cells (Fig. 4a)31–34. This evidence concerns the gene BCL2 and cancer.